Venture Capital

Xilis draws in $70M in funding to bring down costs of drug development | 2021-07-09

Read more at www.bioworld.com

Xilis Inc. closed $70 million in series A financing on July 8 to reduce drug development costs leveraging its technology, with the goal of advancing precision medicine through targeted drug discovery and development. The financing was led by Mubadala Capital with participation from new investors that include GV, formerly Google Ventures, and others.

BioWorld BioWorld MedTech Financings Private Series A

Read more at www.bioworld.com

Show More

Related Articles

Back to top button